The IGNITE Pharmacogenetics Working Group: An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real-World Setting

L. H. Cavallari; A. L. Beitelshees; K. V. Blake; L. G. Dressler; J. D. Duarte; A. Elsey; J. N. Eichmeyer; P. E. Empey; J. P. Franciosi; J. K. Hicks; A. M. Holmes; L. J.B. Jeng; C. R. Lee; J. J. Lima; N. A. Limdi; J. Modlin; A. O. Obeng; N. Petry; V. M. Pratt; T. C. Skaar; S. Tuteja; D. Voora; M. Wagner; K. W. Weitzel; R. A. Wilke; J. F. Peterson; J. A. Johnson

doi:10.1111/cts.12456

The IGNITE Pharmacogenetics Working Group: An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real-World Setting

L. H. Cavallari, A. L. Beitelshees, K. V. Blake, L. G. Dressler, J. D. Duarte, A. Elsey, J. N. Eichmeyer, P. E. Empey, J. P. Franciosi, J. K. Hicks, A. M. Holmes, L. J.B. Jeng, C. R. Lee, J. J. Lima, N. A. Limdi, J. Modlin, A. O. Obeng, N. Petry, V. M. Pratt, T. C. SkaarS. Tuteja, D. Voora, M. Wagner, K. W. Weitzel, R. A. Wilke, J. F. Peterson, J. A. Johnson

Research output: Contribution to journal › Review article › peer-review

68 Scopus citations

Original language	English
Pages (from-to)	143-146
Number of pages	4
Journal	Clinical and Translational Science
Volume	10
Issue number	3
DOIs	https://doi.org/10.1111/cts.12456
State	Published - May 2017

Access to Document

10.1111/cts.12456

Cite this

Cavallari, L. H., Beitelshees, A. L., Blake, K. V., Dressler, L. G., Duarte, J. D., Elsey, A., Eichmeyer, J. N., Empey, P. E., Franciosi, J. P., Hicks, J. K., Holmes, A. M., Jeng, L. J. B., Lee, C. R., Lima, J. J., Limdi, N. A., Modlin, J., Obeng, A. O., Petry, N., Pratt, V. M., ... Johnson, J. A. (2017). The IGNITE Pharmacogenetics Working Group: An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real-World Setting. Clinical and Translational Science, 10(3), 143-146. https://doi.org/10.1111/cts.12456

@article{9d1c4a8fba434cf996123443de96e0bc,

title = "The IGNITE Pharmacogenetics Working Group: An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real-World Setting",

author = "Cavallari, {L. H.} and Beitelshees, {A. L.} and Blake, {K. V.} and Dressler, {L. G.} and Duarte, {J. D.} and A. Elsey and Eichmeyer, {J. N.} and Empey, {P. E.} and Franciosi, {J. P.} and Hicks, {J. K.} and Holmes, {A. M.} and Jeng, {L. J.B.} and Lee, {C. R.} and Lima, {J. J.} and Limdi, {N. A.} and J. Modlin and Obeng, {A. O.} and N. Petry and Pratt, {V. M.} and Skaar, {T. C.} and S. Tuteja and D. Voora and M. Wagner and Weitzel, {K. W.} and Wilke, {R. A.} and Peterson, {J. F.} and Johnson, {J. A.}",

note = "Funding Information: Acknowledgments. Work supported by the National Institutes of Health (NIH) grants U01 HG007269 (LHC, KWW, AE, JAJ), U01 HG007775 (LJJ), U01 HG007253 (JFP, RAW), and U01 HG007762 (TCS, VMP, AMH), as part of the NIH IGNITE network. Additional support provided by NIH U01 GM074492 and U01 HL105198 (both part of the NIH Pharmacoge-nomics Research Network), and by substantial institutional support from the University of Florida and its Clinical Translational Science Institute (UL1 TR000064 and UL1 TR001427) for LHC, EA, KWW, and JAJ; NIH U01 HL105198, and support from the University of Maryland Medical Center and University of Maryland School of Medicine Program for Personalized and Genomic Medicine for ALB and LJBJ; NIH K23 GM112014 and the University of Illinois at Chicago Offices of the Vice President for Health Affairs and Vice Chancellor for Research for JDD; American Society of Health System Pharmacists, NIH UL1TR0000005, and by an Anonymous Donor for PEE; Penn Center for Precision Medicine at the Perelman School of Medicine at the University of Pennsylvania for ST; NIH R01HL092173, 1K24HL133373, University of Alabama, Birmingham Health Service Foundations{\textquoteright} General Endowment Fund, and NIH UL1TR000165 for NAL; R01 GM088076 for TCS; Indiana University Health – Indiana University School of Medicine Strategic Research Initiative for VMP.",

year = "2017",

month = may,

doi = "10.1111/cts.12456",

language = "English",

volume = "10",

pages = "143--146",

journal = "Clinical and Translational Science",

issn = "1752-8054",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "3",

}

Cavallari, LH, Beitelshees, AL, Blake, KV, Dressler, LG, Duarte, JD, Elsey, A, Eichmeyer, JN, Empey, PE, Franciosi, JP, Hicks, JK, Holmes, AM, Jeng, LJB, Lee, CR, Lima, JJ, Limdi, NA, Modlin, J, Obeng, AO, Petry, N, Pratt, VM, Skaar, TC, Tuteja, S, Voora, D, Wagner, M, Weitzel, KW, Wilke, RA, Peterson, JF & Johnson, JA 2017, 'The IGNITE Pharmacogenetics Working Group: An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real-World Setting', Clinical and Translational Science, vol. 10, no. 3, pp. 143-146. https://doi.org/10.1111/cts.12456

TY - JOUR

T1 - The IGNITE Pharmacogenetics Working Group

T2 - An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real-World Setting

AU - Cavallari, L. H.

AU - Beitelshees, A. L.

AU - Blake, K. V.

AU - Dressler, L. G.

AU - Duarte, J. D.

AU - Elsey, A.

AU - Eichmeyer, J. N.

AU - Empey, P. E.

AU - Franciosi, J. P.

AU - Hicks, J. K.

AU - Holmes, A. M.

AU - Jeng, L. J.B.

AU - Lee, C. R.

AU - Lima, J. J.

AU - Limdi, N. A.

AU - Modlin, J.

AU - Obeng, A. O.

AU - Petry, N.

AU - Pratt, V. M.

AU - Skaar, T. C.

AU - Tuteja, S.

AU - Voora, D.

AU - Wagner, M.

AU - Weitzel, K. W.

AU - Wilke, R. A.

AU - Peterson, J. F.

AU - Johnson, J. A.

N1 - Funding Information: Acknowledgments. Work supported by the National Institutes of Health (NIH) grants U01 HG007269 (LHC, KWW, AE, JAJ), U01 HG007775 (LJJ), U01 HG007253 (JFP, RAW), and U01 HG007762 (TCS, VMP, AMH), as part of the NIH IGNITE network. Additional support provided by NIH U01 GM074492 and U01 HL105198 (both part of the NIH Pharmacoge-nomics Research Network), and by substantial institutional support from the University of Florida and its Clinical Translational Science Institute (UL1 TR000064 and UL1 TR001427) for LHC, EA, KWW, and JAJ; NIH U01 HL105198, and support from the University of Maryland Medical Center and University of Maryland School of Medicine Program for Personalized and Genomic Medicine for ALB and LJBJ; NIH K23 GM112014 and the University of Illinois at Chicago Offices of the Vice President for Health Affairs and Vice Chancellor for Research for JDD; American Society of Health System Pharmacists, NIH UL1TR0000005, and by an Anonymous Donor for PEE; Penn Center for Precision Medicine at the Perelman School of Medicine at the University of Pennsylvania for ST; NIH R01HL092173, 1K24HL133373, University of Alabama, Birmingham Health Service Foundations’ General Endowment Fund, and NIH UL1TR000165 for NAL; R01 GM088076 for TCS; Indiana University Health – Indiana University School of Medicine Strategic Research Initiative for VMP.

PY - 2017/5

Y1 - 2017/5

UR - http://www.scopus.com/inward/record.url?scp=85015295644&partnerID=8YFLogxK

U2 - 10.1111/cts.12456

DO - 10.1111/cts.12456

M3 - Review article

C2 - 28294551

AN - SCOPUS:85015295644

SN - 1752-8054

VL - 10

SP - 143

EP - 146

JO - Clinical and Translational Science

JF - Clinical and Translational Science

IS - 3

ER -